Skip to main content
. 2016 Aug 22;7(49):80493–80507. doi: 10.18632/oncotarget.11492

Table 1. Patients’ clinicopathologic features compared with KIF-2C expression.

Variable Cases, n (%) KIF-2C, n (%) P*
<2.0 ≥2.0
Age (years) 0.165
 ≤ 57.0 197(47.5) 102(51.0) 95(44.2)
 > 57.0 218(52.5) 98 (49.0) 120 (55.8)
Sex 0.148
 Male 308(74.2) 142 (71.0) 166 (77.2)
 Female 107 (25.8) 58 (29.0) 49 (22.8)
Location 0.443
 Upper 26 (6.3) 13 (6.5) 13 (6.0)
 Middle 286(68.9) 132(66.0) 154 (71.6)
 Lower 103 (24.8) 55 (27.5) 48 (22.3)
Differentiation 0.022
 Well 63 (15.2) 40 (20.0) 23 (10.7)
 Moderate 277(66.7) 129 (64.5) 148 (68.8)
 Poor 75 (18.1) 31 (15.5) 44 (20.5)
pT status 0.038
 T1 20 (4.8) 13 (6.5) 7 (3.3)
 T2 101 (24.3) 39 (19.5) 62 (28.8)
 T3 294(70.8) 148 (74.0) 146 (67.9)
pN status 0.713
 N0 227(54.7) 112 (56.0) 115 (53.5)
 N1 107(25.8) 53 (26.5) 54 (25.1)
 N2 65(15.7) 27 (13.5) 38 (17.7)
 N3 16(3.9) 8 (4.0) 8 (3.7)
pTNM Stage 0.962
 I 24 (5.8) 12 (6.0) 12 (5.6)
 II 233(56.1) 111 (55.5) 122 (56.7)
 III 158(38.1) 77 (38.5) 81 (37.7)
Surgery 0.824
 Unqualified 135 64 (32.0) 71 (32.5)
 Qualified 280 136 (68.0) 144 (67.5)
Total 415(100) 200(48.2) 215(51.8)

pT, Pathologic tumor; pN, Pathologic node; Qualified surgery, R0 resection with at least 12 resected lymph nodes; Unqualified surgery, R0 resection with less than 12 resected lymph nodes.

*

Chi-square test

Median age